GALENOS – Overview


GALENOS: Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis


A new living evidence resource of early phase research for research prioritisation in mental health.


The number of research publications is increasing every day, in all scientific areas including mental health. This makes it increasingly more challenging for academics, health professionals and members of the public to read through all the new publications and learn about new evidence that is out there. This is why GALENOS was founded.


This new project aims to tackle these challenges by creating a continuously updated, comprehensive, and trustworthy catalogue of the best scientific literature that allows the mental health community to better identify the research questions that most urgently need to be answered. By creating datasets and insights that are easy to navigate in a state-of-the-art online resource, this project will accelerate discovery science into effective new interventions, and solutions for the 1 in 4 of us impacted by mental illness.


Our vision

  • Pull together the best early-phase science, synthesise, and focus to avoid previous mistakes.
  • Meaningful collaboration between academics and experts by experience.
  • Truly global.

The benefits

  • From mechanisms to outcomes.
  • 24 living systematic reviews in 3 years.
  • Open access and made freely available.
  • International crowd.
  • Reviews will be published in full.


What do we cover?

We will provide a programme of living evidence syntheses and research priority setting with a focus on anxiety, depression, and psychosis. We will synthesise scientific findings from foundation science, early translational studies, or late translational trials in relation to:

a) Diagnostic, prognostic, and predictive tools,

b) Pharmacological treatments,

c) Non-pharmacological treatments (these can range from self-care to healthcare, community provision to structural change).


As part of our mission, we encourage the dissemination of all findings to as many academics, health professionals, and members of the public.